Management of Goiter
The management of goiter depends primarily on whether it is causing compressive symptoms, thyroid dysfunction, or suspicion of malignancy—surgery (total thyroidectomy) is the definitive treatment for symptomatic or large goiters (≥80g), while observation is appropriate for asymptomatic euthyroid goiters without malignancy concerns. 1
Initial Diagnostic Approach
Before determining management, establish:
- Thyroid function status: Measure TSH first in all patients 2
- If TSH is low: Obtain radioactive iodine uptake (RAIU) and thyroid scan to identify toxic adenoma or toxic multinodular goiter (TMNG) 1
- Thyroid ultrasound: Essential in all patients to assess nodule characteristics, size, and apply risk stratification 3, 2
- Cross-sectional imaging (CT/MRI): Reserved for substernal extension, retrotracheal involvement, or assessment of tracheal/esophageal compression 3
Management Algorithm Based on Clinical Presentation
For Euthyroid (Non-Toxic) Goiter
Observation is appropriate when:
- Asymptomatic patients
- No compressive symptoms
- No suspicion of malignancy on ultrasound
- Small to moderate size 4, 2
Surgery (Total Thyroidectomy) is indicated when:
- Large goiter (>80g) 1
- Compressive symptoms: dysphagia, dyspnea, orthopnea, neck tightness 1, 5
- Substernal or retrosternal extension 1
- Suspicion of malignancy on ultrasound or cytology 1, 6
- Coexisting hyperparathyroidism requiring surgery 1
Key surgical principle: Total thyroidectomy is superior to subtotal thyroidectomy for multinodular goiter, with essentially zero recurrence (0-0.3%) compared to 2.5-42% after subtotal resection, without increased risk of permanent complications 7. All patients undergoing total thyroidectomy for compressive symptoms achieve symptom resolution 1.
Medical therapy has limited role:
- Levothyroxine suppression shows modest benefit (22% vs 10% nodule reduction >50%) but is controversial and not definitive 8, 7
- Radioactive iodine (RAI) reduces goiter volume by only 30-50% and improves compressive symptoms in only 46% of patients 1
For Toxic Multinodular Goiter (TMNG) or Toxic Adenoma (TA)
Three treatment options exist: radioactive iodine (131I), antithyroid drugs (ATDs), or surgery 1
Choose Surgery (Total Thyroidectomy) when:
- Compressive symptoms or signs 1
- Large goiter (>80g) 1
- Substernal/retrosternal extension 1
- Concern for coexisting thyroid cancer 1
- Need for rapid correction of thyrotoxicosis 1
- RAIU insufficient for therapy 1
- Pregnancy planned within 4-6 months 1
Surgery provides immediate resolution with <1% treatment failure for TA and 100% resolution of compressive symptoms for TMNG 1. Risks include permanent hypoparathyroidism (<2%) and recurrent laryngeal nerve injury (<2%) 1.
Choose Radioactive Iodine (131I) when:
- Advanced age 1
- Significant comorbidities (cardiopulmonary disease) 1
- Small goiter size 1
- Prior neck surgery/scarring 1
- No access to high-volume thyroid surgeon 1
Critical limitation: RAI only reduces goiter volume by 30-50%, with only 46% of patients experiencing improvement in compressive symptoms 1. Progressive hypothyroidism occurs in 64% at 24 years for TMNG and 60% at 20 years for TA 1.
Choose Antithyroid Drugs when:
- High likelihood of remission (mild disease, small goiters, low TRAb) 1
- Elderly with limited life expectancy 1
- Unable to comply with radiation safety 1
- Moderate to severe active Graves' ophthalmopathy (if Graves' disease) 1
Use methimazole preferentially over propylthiouracil except in first trimester pregnancy 1.
Absolute Contraindications to RAI:
- Pregnancy
- Lactation
- Coexisting thyroid cancer
- Unable to comply with radiation safety
- Females planning pregnancy within 4-6 months 1
Special Considerations
Symptomatic Management
Beta-blockers (propranolol, atenolol, metoprolol) should be given to:
- Elderly patients with symptomatic thyrotoxicosis
- Resting heart rate >90 bpm
- Coexistent cardiovascular disease 1
Elderly Patients
In elderly patients with subclinical hyperthyroidism (TSH <0.4 mIU/L) and large multinodular goiter (>40-60mL), total thyroidectomy is recommended if no major cardiovascular risk factors exist 9.
Common Pitfalls to Avoid
Do not use RAI for large compressive goiters: Only 46% improve symptomatically and volume reduction is inadequate 1
Avoid subtotal thyroidectomy: Recurrence rates of 2.5-42% versus essentially zero with total thyroidectomy, without increased complication rates 7
Do not perform thyroidectomy in first or third trimester: If surgery absolutely necessary in pregnancy, perform in second trimester 1
Redo surgery is significantly more morbid: Permanent hypoparathyroidism (0-22% vs 0-4%) and RLN injury (0-13% vs 0-4%) are much higher in reoperations 7
Ensure access to high-volume thyroid surgeon: Surgical outcomes are operator-dependent 1, 5